Coagulase-Negative Staph: From Skin Flora to Pathogen

Coagulase-negative staphylococci, commonly shortened to CoNS, are a large group of Staphylococcus species that lack the coagulase enzyme used to distinguish them from their more infamous relative, Staphylococcus aureus. They are the most abundant bacteria living on human skin, and most of the time they are harmless or even helpful. But under the right circumstances, particularly when medical devices enter the picture, CoNS shift from quiet residents to stubborn opportunistic pathogens responsible for a large share of hospital-acquired infections.

What Makes Them “Coagulase Negative”

The name is defined by an absence. Coagulase is an enzyme that clots blood plasma, and it is the classic lab test used to separate S. aureus (coagulase-positive) from essentially every other staphylococcal species. If a staphylococcus isolate does not clot plasma in a tube test, it lands in the CoNS bin. This negative-definition approach has always been a bit awkward, because it lumps together a huge number of genetically and clinically distinct species under one umbrella label. Genomic studies have now delineated at least 55 CoNS species based on differences in core and accessory genes.¹ Recent taxonomic work has even moved some species formerly classified as staphylococci into a separate genus, Mammaliicoccus, reflecting how deep the evolutionary divergence runs within what used to be treated as one big group.²

Interestingly, coagulase positivity itself has been gained and lost multiple times during staphylococcal evolution. Whole-genome phylogenetic analysis shows that the gene encoding one form of coagulase was acquired on at least four separate occasions across the genus, followed by diversification through mutation and recombination.³ So “coagulase-negative” is not a single evolutionary lineage; it is a grab-bag of species whose shared trait is simply not having that one enzyme.

Friendly Residents on Your Skin

The species you are most likely carrying right now is Staphylococcus epidermidis, and it is far from a passive hitchhiker. S. epidermidis actively primes the skin’s immune defenses, helps maintain skin homeostasis, and prevents opportunistic pathogens from gaining a foothold through what microbiologists call colonization resistance.⁴ Other CoNS species do similar work. Skin-dwelling CoNS can prime immune cells, compete with invaders by producing antimicrobial molecules, and interfere with signaling pathways that pathogens rely on to establish themselves.⁵

One particularly striking example involves acne. Co-culture experiments with hundreds of staphylococcal strains found that S. epidermidis can selectively exclude acne-associated strains of Cutibacterium acnes while leaving healthy-skin-associated strains alone.⁶ A separate team identified a strain of Staphylococcus capitis that killed C. acnes more potently than common acne antibiotics, using small antimicrobial peptides called phenol-soluble modulins. Those peptides were not toxic to human skin cells and did not harm other commensal bacteria, raising the possibility of a targeted probiotic-style acne treatment.⁷ CoNS lipases also play a role in skin biochemistry, converting fatty acids into wax esters and back, which affects the chemical landscape other microbes must navigate.⁸

When CoNS Turn Pathogenic

The shift from commensal to pathogen almost always involves a breach in the body’s normal barriers. The single biggest risk factor is an implanted medical device: a central venous catheter, a prosthetic joint, a heart valve, a cerebrospinal fluid shunt, or any other foreign material that CoNS can attach to. These devices serve as scaffolds for biofilm formation, and once a biofilm takes hold the infection becomes extremely difficult to clear.⁹ Most catheter-related and prosthetic joint infections, along with most other device-related infections, are caused by CoNS, with S. epidermidis and S. haemolyticus being the leading culprits.¹⁰

Premature and critically ill newborns face particular danger. The same interventions keeping these infants alive, intravenous lines, ventilators, prolonged hospital stays, simultaneously expose them to CoNS bloodstream infections. CoNS are the predominant cause of neonatal sepsis in intensive care settings, and the health burden from these infections remains high despite decades of infection-control efforts.¹¹

Biofilm Formation and Why It Matters

Biofilm is the central weapon in the CoNS pathogenic arsenal. When CoNS land on a device surface, they secrete sticky matrix molecules that cement them in place and build a layered community. Bacteria buried inside a biofilm are physically shielded from antibiotics and from the immune system’s neutrophils, which is why device infections often smolder for weeks or months rather than causing the dramatic, acute illness typical of S. aureus. Studies of clinical CoNS isolates consistently find that a majority form biofilm, though reported rates depend on the detection method: one study using a tissue-culture plate assay found biofilm in about 38% of isolates, while a Congo red agar method flagged about 87% from the same set of samples.¹² A separate hospital study found biofilm in roughly two-thirds of clinical CoNS isolates.¹³

Phenol-soluble modulins, the same peptide family that helps some CoNS fight off C. acnes on healthy skin, also play a role inside biofilms. In S. epidermidis, certain PSM variants structure the biofilm itself, creating internal channels that allow nutrients to reach deeper layers. Those same peptides also trigger the detachment of biofilm clusters, which is how the infection can seed new sites, including the bloodstream.¹⁴ Endemic CoNS clones circulating in neonatal units have been shown to carry high rates of biofilm-associated genes and the ica operon, which encodes the polysaccharide intercellular adhesin that glues cells together. All isolates from the two largest persistent clusters in one 12-year neonatal unit survey were ica-positive, and PSM genes were more common in these endemic strains than in sporadic ones.¹⁵

Species That Break the Mold

Not all CoNS behave like mild, slow-burning device pathogens. A few species deserve individual attention because they act very differently from the S. epidermidis archetype.

Staphylococcus lugdunensis is the most dramatic outlier. It lives on skin like other CoNS, but when it causes infection it behaves much more like S. aureus. It can cause acute, highly destructive native-valve endocarditis that often demands surgical intervention on top of antibiotics.¹⁶ It carries a diverse set of virulence factors for adhesion, cell damage, and immune evasion, though these are still less numerous than those in S. aureus.¹⁷ The clinical significance here is that labs and clinicians should not dismiss a CoNS blood culture isolate as “just a contaminant” before identifying the species. If it turns out to be S. lugdunensis, the stakes are considerably higher.

Staphylococcus saprophyticus occupies a completely different niche. It is a leading cause of urinary tract infections in young women, second only to E. coli in community-acquired UTIs. In one large study, S. saprophyticus accounted for about 22% of UTIs among female outpatients overall, and over 42% among women aged 16 to 25.¹⁸ Patients typically present with classic UTI symptoms: burning during urination and sometimes back pain.¹⁹ Unlike device-related CoNS infections, S. saprophyticus UTIs happen in healthy people with no catheters or implants. The bacterium has a specific affinity for cells lining the urinary tract, which is why it causes trouble there rather than on skin.

Staphylococcus haemolyticus deserves mention as an emerging problem. It ranks just behind S. epidermidis among hospital-acquired CoNS infections and is notorious for rapidly acquiring antibiotic resistance. Recent work shows it can evade neutrophil killing by triggering weaker immune traps than S. aureus and resisting the antimicrobial activity of those traps more effectively.²⁰

The Contamination Problem

Because CoNS blanket human skin, they are the most frequent contaminants of blood cultures. Every time a needle punctures the skin to draw blood, there is a chance skin bacteria get swept into the sample. The result is a headache for clinicians: a blood culture grows CoNS, but is it a true bloodstream infection or just a skin contaminant that snuck in during collection? This distinction matters enormously because true CoNS bacteremia sometimes requires weeks of intravenous antibiotics and device removal, while contamination requires nothing.

Several clues help sort this out. How quickly the culture bottle flags positive is one. Bottles that turn positive within about 16 hours tend to reflect high bacterial loads consistent with real infection, while bottles that take more than 20 hours are more likely contaminants.²¹ The pattern of which bottles turn positive and how long it takes can be combined with clinical assessment as a practical diagnostic tool.²²

Clinical signs also help. A prospective study of over 650 patients found that the probability of a true bloodstream infection climbed sharply with the number of signs of systemic inflammation present, and the presence of a central venous line was the single strongest independent predictor of true infection.²³ The traditional recommendation of drawing two separate blood cultures still holds: CoNS growing in two independently collected sets is much more suggestive of real infection than a single positive bottle.

Identifying CoNS to the Species Level

For decades, labs often reported CoNS simply as “coagulase-negative staphylococci” without specifying the species, because the traditional biochemical methods for species identification were slow and unreliable. This changed with the widespread adoption of MALDI-TOF mass spectrometry, a technology that identifies bacteria by their protein fingerprint in minutes. Head-to-head comparisons showed MALDI-TOF correctly identified CoNS species in over 93% of cases, compared with about 75% for older automated systems.²⁴ Other validation work found 100% agreement between MALDI-TOF and gene sequencing for routinely encountered CoNS species.²⁵

Accurate species identification is clinically useful because species identity changes the clinical picture. As noted above, S. lugdunensis demands aggressive treatment, S. saprophyticus points to a urinary source, and S. haemolyticus often carries extensive resistance. Some species like S. capitis have been linked to specific infection settings, including prosthetic joint infections that tend to present as chronic rather than blood-borne.²⁶

Antibiotic Resistance and the Gene-Sharing Problem

CoNS are among the most antibiotic-resistant organisms in hospitals. The key piece of genetic hardware is the SCCmec cassette, a mobile genetic element carrying the mecA gene that confers resistance to methicillin and related antibiotics. At least nine types of SCCmec have been identified across CoNS species, and this cassette can jump between species through horizontal gene transfer.²⁷ The concern is not just that CoNS themselves are resistant. It is that CoNS act as a reservoir of resistance genes sitting on the skin of almost every hospitalized patient, genes that can potentially transfer to S. aureus and other more dangerous species.²⁸

Even vancomycin, long considered the last reliable option for resistant staphylococci, is not invulnerable. In one neonatal intensive care unit, about 4% of CoNS isolates showed decreased vancomycin susceptibility, and most of those were a single species, S. warneri, spreading clonally among infants who had been hospitalized for over four weeks and exposed to vancomycin.²⁹ Situations like this explain why infectious disease specialists keep a close eye on CoNS susceptibility patterns even though individual CoNS infections are often manageable.

Managing CoNS Infections

For the most common scenario, a catheter-related bloodstream infection caused by CoNS, the first question clinicians face is whether the catheter needs to come out. If it can be removed, the infection often resolves without antibiotics. One study found that withholding antibiotics when the catheter was removed was not associated with short-term complications or long-term recurrences.³⁰ When the catheter cannot be removed, usually because the patient has no other vascular access, clinicians turn to antibiotic lock therapy: filling the catheter lumen with a concentrated antibiotic solution that sits in contact with the biofilm for hours. In an in vivo comparison, daptomycin locks achieved an 85% eradication rate, far outperforming standard-of-care approaches, which succeeded only about 30% of the time.³¹

There is also interest in non-antibiotic lock solutions. In vitro work showed that 40% ethanol killed CoNS biofilm cells within one hour, outperforming conventional antibiotics that required high concentrations and long dwell times.³² Ethanol locks are attractive because they bypass the resistance problem entirely: ethanol kills by physically disrupting cell membranes, so bacteria cannot readily evolve resistance to it the way they do with antibiotics.

CoNS in Veterinary Medicine

CoNS are not just a human problem. In dairy farming, they have become the most common cause of bovine mastitis in many countries. The infection usually stays subclinical, meaning the cow does not look obviously sick, but it raises the somatic cell count in milk, reduces milk quality, and can damage udder tissue over time, leading to decreased production. The predominant species in cattle are S. simulans and S. chromogenes, different from the S. epidermidis and S. haemolyticus that dominate human infections.³³ A meta-analysis of Chinese dairy herds found a pooled CoNS prevalence of about 17%, with rates higher in clinical mastitis than in subclinical cases and rising over recent decades.³⁴

The veterinary CoNS problem intersects with human concerns through antimicrobial resistance. Resistance genes in livestock-associated CoNS can potentially enter the broader staphylococcal gene pool, especially since horizontal gene transfer is rampant across CoNS species. The same SCCmec cassettes that make human CoNS resistant to methicillin have been identified in bovine isolates, raising the prospect of resistance moving between farm and hospital ecosystems.